DocWire News Editors

DocwireNews

Ironically enough, elements of the Ebola virus may be used to <a href="https://www.docwirenews.com/docwire-pick/future-of-medicine-picks/improved-microfluidic-brain-cancer-chip-tests-and-analyzes-chemotherapies/">combat</a> glioblastomas, according to a study which appeared in the Journal of Virology.The approach takes advantage of a weakness in most cancer tumors and also of an Ebola defense against the immune system response to pathogens.Unlike normal cells, a large percentage of cancer cells lack the ability to generate an innate immune response against invaders such as viruses. This has led cancer researchers to explore the use of viruses to combat a variety of cancers.Prof. Ven den Pol and the study&rsquo;s first author, Xue Zhang, also of Yale, used a chimeric virus containing one of gene from the Ebola virus &mdash; a glycoprotein with a mucin-line domain (MLD). They then injected this chimeric virus into the brains of mice with glioblastoma and found that the MLD helped selectively target and kill deadly glioblastoma brain tumors.&ldquo;The irony is that one of the world&rsquo;s deadliest viruses may be useful in treating one of the deadliest of brain cancers,&rdquo; said Yale&rsquo;s Anthony van den Pol, professor of neurosurgery in a press release.Van den Pol said MLD&rsquo;s beneficial effect appears to be that it protects normal cells from infection &mdash; but not cancer cells, which lack the ability to mount an immune response to pathogens.A key factor may be that the virus with the glycoprotein MLD replicates less rapidly, potentially making it safer than viruses without the MLD part of the glycoprotein, he said.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Scientists find ally in fight against brain tumors: Ebola <a href="https://t.co/ghx6PcLJlP">https://t.co/ghx6PcLJlP</a> <a href="https://t.co/79Km6n38aS">pic.twitter.com/79Km6n38aS</a>
&mdash; Bioengineer.org (@bioengineerorg) <a href="https://twitter.com/bioengineerorg/status/1227679315556524034?ref_src=twsrc%5Etfw">February 12, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;In theory, such a virus might be used in conjunction with surgery to eliminate glioblastoma tumors and help prevent a recurrence of cancer, he said.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Scientists find ally in fight against brain tumors: Ebola | YaleNews &#129327;&#129327;&#129327; <a href="https://t.co/vReQgLtVCY">https://t.co/vReQgLtVCY</a>
&mdash; Daniel A. Col&oacute;n R&iacute;os (@DanielColonRios) <a href="https://twitter.com/DanielColonRios/status/1228042223822004225?ref_src=twsrc%5Etfw">February 13, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Scientists find ally in fight against brain tumors: Ebola
"The irony is that one of the world's deadliest viruses may be useful in treating one of the deadliest of brain cancers."<a href="https://twitter.com/hashtag/neuroscience?src=hash&amp;ref_src=twsrc%5Etfw">#neuroscience</a> <a href="https://t.co/LdCe2WTeCF">https://t.co/LdCe2WTeCF</a>
&mdash; Matt Perez &#129320; RADICAL (@matt_perez) <a href="https://twitter.com/matt_perez/status/1228043165094907904?ref_src=twsrc%5Etfw">February 13, 2020</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&nbsp;&nbsp;

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Can the Ebola Virus be Used to Combat Brain Cancer?

Oncology

Ironically enough, elements of the Ebola virus may be used to combat glioblastomas, according to a study which appeared in the Journal of Virology. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe